Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Ryanair
RYAAY
$30.4B
| $76.9K | ﹤0.01% |
+1,738
| New | +$70.1K |
|
3502
Atlanticus Holdings
ATLC
$1.59B
| $76.8K | ﹤0.01% |
1,828
-271
| -13% | -$8.9K |
|
3503
Inogen
INGN
$175M
| $76.2K | ﹤0.01% |
6,595
-7,102
| -52% | -$83.7K |
|
|
WKME
3504
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $76.1K | ﹤0.01% |
+7,924
| New | +$76.8K |
|
|
ABPWW
3505
DELISTED
Abpro Holdings Warrant
ABPWW
| $76K | ﹤0.01% |
250,000
| – | – |
|
3506
Liquidia Corp
LQDA
$7.48B
| $75.6K | ﹤0.01% |
9,632
-14,588
| -60% | -$113K |
|
3507
inTEST
INTT
$155M
| $75.4K | ﹤0.01% |
2,872
-4,575
| -61% | -$101K |
|
|
GRTS
3508
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $75.4K | ﹤0.01% |
38,662
-34,013
| -47% | -$79.6K |
|
3509
YPF
YPF
$206B
| $75.3K | ﹤0.01% |
5,060
+5,000
| +8,333% | +$60.6K |
|
3510
SoundThinking
SSTI
$100M
| $75.2K | ﹤0.01% |
3,441
-1,095
| -24% | -$28.7K |
|
3511
Cooper-Standard Automotive
CPS
$523M
| $75.1K | ﹤0.01% |
5,269
+3,527
| +202% | +$43K |
|
|
ATXS
3512
DELISTED
Astria Therapeutics
ATXS
| $75.1K | ﹤0.01% |
9,010
-23,987
| -73% | -$277K |
|
3513
Carter Bankshares
CARE
$766M
| $74.7K | ﹤0.01% |
5,050
-6,994
| -58% | -$98.9K |
|
|
CRON
3514
Cronos Group
CRON
$1.06B
| $74.6K | ﹤0.01% |
+37,857
| New | +$69.3K |
|
|
NREF
3515
NexPoint Real Estate Finance
NREF
$320M
| $74.4K | ﹤0.01% |
4,774
+622
| +15% | +$8.9K |
|
|
QIPT
3516
DELISTED
Quipt Home Medical
QIPT
| $74.4K | ﹤0.01% |
13,937
+1,609
| +13% | +$9.5K |
|
3517
Viemed Healthcare
VMD
$447M
| $74.4K | ﹤0.01% |
7,606
-7,790
| -51% | -$79.1K |
|
3518
SelectQuote
SLQT
$132M
| $74K | ﹤0.01% |
37,931
-41,553
| -52% | -$70K |
|
3519
NewtekOne
NEWT
$428M
| $73.6K | ﹤0.01% |
+4,630
| New | +$61K |
|
3520
iShares Cybersecurity and Tech ETF
IHAK
$1B
| $73.4K | ﹤0.01% |
1,941
| – | – |
|
3521
Biglari Holdings Class B
BH
$1.25B
| $73.1K | ﹤0.01% |
371
-742
| -67% | -$139K |
|
3522
Vanguard Morningstar Value ETF
VTV
$188B
| $72.8K | ﹤0.01% |
512
+319
| +165% | +$44.3K |
|
3523
Weave Communications
WEAV
$520M
| $72.6K | ﹤0.01% |
6,535
-9,440
| -59% | -$63.1K |
|
3524
Voyager Therapeutics
VYGR
$183M
| $72.6K | ﹤0.01% |
6,339
-29,097
| -82% | -$301K |
|
|
NSTG
3525
DELISTED
NanoString Technologies, Inc.
NSTG
| $72.3K | ﹤0.01% |
17,846
-25,363
| -59% | -$187K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.